Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.85    0.00 (0.00%)
Bid:
1.51
Ask:
1.85
Spread: 0.34 (22.517%)
Market Cap: £37.11m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Replacement: Business Update

16 May 2023 16:29

RNS Number : 6222Z
Quadrise PLC
16 May 2023
 

The following amendment has been made to the "Business Update" announcement released on 16 May 2023 at 07:00 under RNS No. 4889Z.

The original announcement stated that Valkor had been awarded drilling permits covering their Asphalt Ridge site in early May 2023. The corrected announcement below states that the drilling permits are expected to be awarded later in May 2023

All other details remain unchanged. The full amended text is shown below.

 

16 May 2023

Quadrise Plc ("Quadrise" or the "Company")

Business Update

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, is pleased to provide an update covering progress on each of its key projects.

Key projects:

· Morocco - The industrial demonstration test is now scheduled to commence in May following finalisation of the client's latest production schedule. Quadrise personnel are now at the client site completing trial preparation, with results expected shortly after completion of testing and joint review with the client. Upon success, the parties will enter discussions for potential commercial supply, with a view to signing a fuel supply agreement in Q3 2023.

· MSC - Discussions with third party fuel suppliers for the Proof-of-Concept and Letter of No Objection trials on board the MSC Leandra are progressing positively. The intended outcome of these discussions is to conclude a Tripartite Agreement between the supplier, MSC and Quadrise as soon as possible. The vessel is currently in dry dock being prepared for testing, which is now expected to commence in Q4 2023. Quadrise and MSC are scheduling the bioMSAR™ hazard identification and operability study as recommended by Wärtsilä, which assesses feasibility and safe operability prior to use on the vessel's 2-stroke main engine. With positive trial progression, Quadrise, MSC, and other key stakeholders expect to commence discussions in H1 2024 with regard to commercial supply to MSC's fleet.

· Utah - Quadrise and Valkor are finalising terms for the supply of a licence, services and manufacturing unit to enable Valkor to produce MSAR® and bioMSAR™ for the first project, and conditional sub-licensing of the technology for other heavy oil projects in Utah. Following the award of drilling permits to Valkor covering their Asphalt Ridge site, expected to be made later in May 2023, the supply of the licence and manufacturing unit will allow low sulphur heavy oil with a lower carbon intensity to be blended to MSAR® and bioMSAR™ for trials during H2 2023, ahead of commercial supply in Q1 2024.

 

Commenting on the update, Jason Miles, Chief Executive Officer of Quadrise, said:

 

"Our key projects are each progressing to their next stage of development, and we look forward to sharing updates as additional milestones are reached.

The Company is entering an exciting period, with commercial revenues expected upon signature of the Valkor agreement, the Morocco trial expected to commence this month and progress continuing with regard to securing a fuel supplier for the MSC trials. In addition, we continue to develop our decarbonisation technologies towards delivering fully net-zero carbon solutions and progress opportunities for our business in other regions and applications."

 

For additional information, please contact:

 

Quadrise Fuels International Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

 

Learn more at: www.quadrise.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDAFMATMTTBBFJ
Date   Source Headline
2nd Aug 20247:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20247:00 amRNSValkor Project Update
10th Jul 20247:00 amRNSMarine Project Update
26th Jun 20247:00 amRNSExtended agreement with BTG Bioliquids for bioMSAR
29th May 20247:00 amRNSRepresentation Agreement Addendum & Warrants Grant
28th May 20247:00 amRNSOCP Commercial Framework Agreement
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.